Indomethacin, ranitidine, and interleukin-2 in melanoma.
T J
TJ
Hamblin
D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000556:secondary; D004359:Drug Therapy, Combination; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary; D011899:Ranitidine / Q000627:therapeutic use*
D007376:Interleukin-2; D011899:Ranitidine; D007213:Indomethacin